Nextech is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland. They focus almost exclusively on oncology therapeutics, and on helping to drive value creation for their portfolio companies. They invest in the most promising drug discovery companies with the potential to create multiple medicines. Their portfolio is focused throughout the US and Europe with investments from company inceptions to crossover rounds.

Venture Capital

Nextech Invest

Partners

Rocco Sgobbo

Thilo Schroeder

Alfred Scheidegger

Jakob Loven

The leadership team at Nextech Invest have a wealth of experience in the biotech industry, with board memberships at companies such as Hexagon Bio, Flare Therapeutics, Boundless Bio, and IconOVir Bio. They also boast impressive educational backgrounds, with degrees from renowned institutions such as the Karolinska Institutet and Anglia Ruskin University.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Nextech Invest

Board of Directors

CEO and Executive Team